These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7023894)

  • 1. Naltrexone treatment of heroin addiction: efficacy and safety in a double-blind dosage comparison.
    Judson BA; Carney TM; Goldstein A
    Drug Alcohol Depend; 1981 Jul; 7(4):325-46. PubMed ID: 7023894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptom complaints of patients maintained on methadone, LAAM (methadyl acetate), and naltrexone at different times in their addiction careers.
    Judson BA; Goldstein A
    Drug Alcohol Depend; 1982; 10(2-3):269-82. PubMed ID: 7166139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of naltrexone treatment of opiate-dependent individuals. Report of the National Research Council Committee on Clinical Evaluation of Narcotic Antagonists.
    Arch Gen Psychiatry; 1978 Mar; 35(3):335-40. PubMed ID: 365122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of naltrexone in preventing reabuse of heroin after detoxification.
    Shufman EN; Porat S; Witztum E; Gandacu D; Bar-Hamburger R; Ginath Y
    Biol Psychiatry; 1994 Jun; 35(12):935-45. PubMed ID: 8080893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naltrexone treatment of heroin addiction: one-year follow-up.
    Judson BA; Goldstein A
    Drug Alcohol Depend; 1984 Jul; 13(4):357-65. PubMed ID: 6479015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term effects of naltrexone in 155 heroin ex-addicts.
    Volavka J; Resnick RB; Kestenbaum RS; Freedman AM
    Biol Psychiatry; 1976 Dec; 11(6):679-85. PubMed ID: 999987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nontolerance to the opioid antagonism of naltrexone.
    Kleber HD; Kosten TR; Gaspari J; Topazian M
    Biol Psychiatry; 1985 Jan; 20(1):66-72. PubMed ID: 2981129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Craving in heroin addicts maintained on the opiate antagonist naltrexone.
    Sideroff SI; Charuvastra VC; Jarvik ME
    Am J Drug Alcohol Abuse; 1978; 5(4):415-23. PubMed ID: 755381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naltrexone in methadone maintenance patients electing to become "drug free".
    Haas N; Ling W; Holmes E; Blakis M; Litaker M
    NIDA Res Monogr; 1976 Sep; (9):70-3. PubMed ID: 794723
    [No Abstract]   [Full Text] [Related]  

  • 10. Naltrexone and behavior therapy for heroin addiction.
    Rawson RA; Glazer M; Callahan EJ; Liberman RP
    NIDA Res Monogr; 1979 Jun; (25):26-43. PubMed ID: 117373
    [No Abstract]   [Full Text] [Related]  

  • 11. Follow-up after a six-month maintenance period on naltrexone versus placebo in heroin addicts.
    San L; Pomarol G; Peri JM; Olle JM; Cami J
    Br J Addict; 1991 Aug; 86(8):983-90. PubMed ID: 1912753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Narcotic antagonists: naltrexone progress report: introduction.
    Renault PF
    NIDA Res Monogr; 1976 Sep; (9):1-3. PubMed ID: 794713
    [No Abstract]   [Full Text] [Related]  

  • 13. NIDA's naltrexone research program.
    Julius D
    NIDA Res Monogr; 1976 Sep; (9):5-11. PubMed ID: 187943
    [No Abstract]   [Full Text] [Related]  

  • 14. Factors influencing success in an antagonistic treatment program.
    Parwatikar S; Crawford J; Nelkupa JV; De Gracia C
    NIDA Res Monogr; 1976 Sep; (9):77-81. PubMed ID: 794725
    [No Abstract]   [Full Text] [Related]  

  • 15. Controlled clinical study of naltrexone side effects comparing first-day doses and maintenance regimens.
    Brahen LS; Capone T; Heller RC; Linden SL; Landy HJ; Lewis MJ
    Am J Drug Alcohol Abuse; 1978; 5(2):235-45. PubMed ID: 747177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonidine and opiate receptor antagonists in the treatment of heroin addiction.
    Gerra G; Marcato A; Caccavari R; Fontanesi B; Delsignore R; Fertonani G; Avanzini P; Rustichelli P; Passeri M
    J Subst Abuse Treat; 1995; 12(1):35-41. PubMed ID: 7752296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The treatment of heroin addiction: naltrexone alone and with behavior therapy.
    Callahan EJ; Rawson RA; McCleave B; Arias R; Glazer M; Liberman RP
    Int J Addict; 1980 Aug; 15(6):795-807. PubMed ID: 7461877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experiences with Naltrexone in Buffalo.
    Taintor Z; Landsberg R; Wicks N
    Am J Drug Alcohol Abuse; 1975; 2(3-4):391-401. PubMed ID: 775969
    [No Abstract]   [Full Text] [Related]  

  • 19. Determination of naltrexone dosage for narcotic agonist blockade in detoxified Asian addicts.
    Navaratnam V; Jamaludin A; Raman N; Mohamed M; Mansor SM
    Drug Alcohol Depend; 1994 Feb; 34(3):231-6. PubMed ID: 8033761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of the National Academy of Sciences study of naltrexone.
    Kaim SC
    NIDA Res Monogr; 1976 Sep; (9):37-44. PubMed ID: 794719
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.